13F

Stock

Allogene Therapeutics, Inc.

ALLO · held by 2 managers

Reported value

$1.62M

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$230K

Price effect on 2 books still in the name

Largest holder

$1.62M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC761.3K$1.62M−$229.8KAdded$661.2K
Leonteq Securities AG351$748−$235Cut−$235

Positions as of Q4 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.